The endocannabinoid system: potential for reducing cardiometabolic risk
- PMID: 19373218
- PMCID: PMC2905146
- DOI: 10.1038/oby.2009.107
The endocannabinoid system: potential for reducing cardiometabolic risk
Figures


Similar articles
-
[Impact of endocannabinoid system in modulation of cardiometabolic risk factors].Vnitr Lek. 2006 Jun;52(6):615-8. Vnitr Lek. 2006. PMID: 16871766 Review. Czech.
-
The endocannabinoid system: a new pharmacological target for obesity treatment?Neurosci Bull. 2009 Jun;25(3):153-60. doi: 10.1007/s12264-009-0112-3. Neurosci Bull. 2009. PMID: 19448689 Free PMC article. Review.
-
[Endocannabinoid and endocannabinoid receptor antagonists].Med Monatsschr Pharm. 2005 Feb;28(2):40-3. Med Monatsschr Pharm. 2005. PMID: 15727333 Review. German. No abstract available.
-
The endocannabinoid system: novel pathway for cardiometabolic Risk-factor reduction.JAAPA. 2007 Nov;Suppl Endocannabinoid:7-10. doi: 10.1097/01720610-200711000-00005. JAAPA. 2007. PMID: 18047036 Review.
-
The endocannabinoid system and cardiovascular risk: pathophysiologic role and developing therapeutic interventions.Am J Geriatr Cardiol. 2006 Jul-Aug;15(4):255-9. doi: 10.1111/j.1076-7460.2006.05083.x. Am J Geriatr Cardiol. 2006. PMID: 16849895 Review. No abstract available.
Cited by
-
Weight loss outcomes are not compromised in bariatric patients using cannabis.Surg Endosc. 2023 Mar;37(3):2194-2201. doi: 10.1007/s00464-022-09453-x. Epub 2022 Jul 21. Surg Endosc. 2023. PMID: 35861881
-
Circulating endocannabinoid levels in pregnant women with gestational diabetes mellitus: a case-control study.BMC Endocr Disord. 2022 Nov 3;22(1):268. doi: 10.1186/s12902-022-01182-5. BMC Endocr Disord. 2022. PMID: 36329422 Free PMC article.
-
Theoretical Explanation for Reduced Body Mass Index and Obesity Rates in Cannabis Users.Cannabis Cannabinoid Res. 2018 Dec 21;3(1):259-271. doi: 10.1089/can.2018.0045. eCollection 2018. Cannabis Cannabinoid Res. 2018. PMID: 30671538 Free PMC article. Review.
-
Cannabis sativa as a Treatment for Obesity: From Anti-Inflammatory Indirect Support to a Promising Metabolic Re-Establishment Target.Cannabis Cannabinoid Res. 2022 Apr;7(2):135-151. doi: 10.1089/can.2021.0016. Epub 2021 Jul 9. Cannabis Cannabinoid Res. 2022. PMID: 34242511 Free PMC article. Review.
-
High-fat diet-induced insulin resistance does not increase plasma anandamide levels or potentiate anandamide insulinotropic effect in isolated canine islets.PLoS One. 2015 Apr 9;10(4):e0123558. doi: 10.1371/journal.pone.0123558. eCollection 2015. PLoS One. 2015. PMID: 25855974 Free PMC article.
References
-
- Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults—The Evidence Report. National Institutes of Health. National Institutes of Health. Obes Res. 1998;6(Suppl 2):51S–209S. - PubMed
-
- Leibel RL, Rosenbaum M, Hirsch J. Changes in energy expenditure resulting from altered body weight. N Engl J Med. 1995;332:621–628. - PubMed
-
- Rosenbaum M, Vandenborne K, Goldsmith R, et al. Effects of experimental weight perturbation on skeletal muscle work efficiency in human subjects. Am J Physiol Regul Integr Comp Physiol. 2003;285:R183–R192. - PubMed
-
- Gong Y, Ishida-Takahashi R, Villanueva EC, et al. The long form of the leptin receptor regulates STAT5 and ribosomal protein S6 via alternate mechanisms. J Biol Chem. 2007;282:31019–31027. - PubMed
-
- Morton GJ, Cummings DE, Baskin DG, Barsh GS, Schwartz MW. Central nervous system control of food intake and body weight. Nature. 2006;443:289–295. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical